Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Kei Kawaguchi, Kentaro Igarashi, Shukuan Li, Qinghong Han, Yuying Tan, Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, Takashi Murakami, Bartosz Chmielowski, Scott D. Nelson, Tara A. Russell, Sarah M. Dry, Yunfeng Li5, Michiaki Unno, Fritz C. Eilber, Robert M. Hoffman
Published Dec 12, 2017 · Vol. 9, No. 1 · pp. 915-923
Leonora S.F. Boogerd, Charlotte E.S. Hoogstins, Katja N. Gaarenstroom, Cornelis D. de Kroon, Jogchum J. Beltman, Tjalling Bosse, Ellen Stelloo, Jaap Vuyk, Philip S. Low, Jacobus Burggraaf, Alexander L. Vahrmeijer
Published Dec 11, 2017 · Vol. 9, No. 1 · pp. 791-801
Shan Zeng, Adrian M. Seifert, Jennifer Q. Zhang, Teresa S. Kim, Timothy G. Bowler, Michael J. Cavnar, Benjamin D. Medina, Gerardo A. Vitiello, Ferdinand Rossi, Jennifer K. Loo, Nesteene J. Param, Ronald P. DeMatteo
Published Dec 11, 2017 · Vol. 8, No. 69 · pp. 114195-114209